Education
About Us
Working with TipRanks
Follow Us
Bayer (DE:BAYN)
XETRA:BAYN
BAYN Stock Chart & Stats
€35.10
€0.08(0.41%)
At close: 4:00 PM EST
€35.10
€0.08(0.41%)
Day’s Range― - ―
52-Week Range€18.38 - €37.14
Previous CloseN/A
Volume533.42K
Average Volume (3M)2.24M
Market Cap
€34.44B
Enterprise Value€59.09B
Total Cash (Recent Filing)€7.24B
Total Debt (Recent Filing)€39.64B
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Mar 03, 2026EPS Estimate
0.32Next Dividend Ex-DateN/A
Dividend Yield0.31%
Share Statistics
EPS (TTM)0.57
Shares Outstanding982,424,100
10 Day Avg. Volume2,239,372
30 Day Avg. Volume2,240,598
Financial Highlights & Ratios
PEG Ratio0.57
Price to Book (P/B)0.59
Price to Sales (P/S)0.41
P/FCF Ratio4.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€35.54Price Target Upside1.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cash Flow MeasuresThe company has implemented measures to maximize cash flow generation, which is crucial given the high level of debt.
Debt ReductionNet debt at €32.6bn (FY-23: 34.5bn), which is good news.
Bears Say
Agrochemicals PerformanceBayer underperformed significantly due to weaker-than-expected agrochemicals performance and questions on long-term pharma growth.
EBITDA DeclineQ4 clean EBITDA came in at EUR 2.35bn, which is materially down y/y (-22% y/y, Stifel: €2.24bn, consensus: €2.1bn).
Generics ImpactThe Crop Science business is facing a broader-than-expected generics impact, affecting the company's overall performance.
Litigation UncertaintyOngoing litigation related to glyphosate is creating uncertainty for investors, with 67,000 cases still unsettled.
Bayer News
BAYN FAQ
What was Bayer’s price range in the past 12 months?
Bayer lowest stock price was €18.38 and its highest was €37.14 in the past 12 months.
What is Bayer’s market cap?
Bayer’s market cap is €34.44B.
When is Bayer’s upcoming earnings report date?
Bayer’s upcoming earnings report date is Mar 03, 2026 which is in 74 days.
How were Bayer’s earnings last quarter?
Bayer released its earnings results on Nov 12, 2025. The company reported €0.57 earnings per share for the quarter, beating the consensus estimate of €0.366 by €0.204.
Is Bayer overvalued?
According to Wall Street analysts Bayer’s price is currently Undervalued.
Does Bayer pay dividends?
Bayer pays a Annually dividend of €0.11 which represents an annual dividend yield of 0.31%. See more information on Bayer dividends here
What is Bayer’s EPS estimate?
Bayer’s EPS estimate is 0.32.
How many shares outstanding does Bayer have?
Bayer has 982,424,100 shares outstanding.
What happened to Bayer’s price movement after its last earnings report?
Bayer reported an EPS of €0.57 in its last earnings report, beating expectations of €0.366. Following the earnings report the stock price went up 5.942%.
Which hedge fund is a major shareholder of Bayer?
Currently, no hedge funds are holding shares in DE:BAYN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bayer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€35.54 (1.25% Upside)
€35.54 (1.25% Upside)
Blogger Sentiment
Bullish
DE:BAYN Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
2.11%
12-Months-Change
Fundamentals
Return on Equity
-0.66%
Trailing 12-Months
Asset Growth
-12.20%
Trailing 12-Months
Company Description
Bayer
Bayer AG is a global life sciences company headquartered in Leverkusen, Germany, with a rich history that dates back to 1863. It operates primarily in three main sectors: Pharmaceuticals, Consumer Health, and Crop Science. Bayer's Pharmaceuticals division focuses on prescription products in areas such as cardiology, oncology, and women's health. The Consumer Health division offers over-the-counter products including pain relievers, dietary supplements, and dermatological solutions. The Crop Science sector provides innovative agricultural solutions, including crop protection, seeds, and digital farming technologies, aimed at enhancing agricultural productivity and sustainability.
BAYN Stock 12 Month Forecast
Average Price Target
€35.54
▲(1.25% Upside)
Technical Analysis
Fresenius Medical Care AG & Co. KGaA
―
Fresenius SE & Co. KGaA
―
Merck KGaA
―
Sartorius
―
Siemens Healthineers AG
―
Options Prices
Currently, No data available
---